References
Garcia-Monco JC, Cortina IE, Ferreira E, Martinez A, Ruiz L, Cabrera A, Beldarrain MG (2011) Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimag 21:e1–e14
Carrara G, Ferlazzo E, Tampieri D, Andermann F, Melanson D (2005) Transient edematous lesions of the splenium in epileptic patients. Can J Neurol Sci 32(3):352–355
Cortese R, Pontrelli G, Mogavero MP, Dicuonzo F, Tortorella C (2015) Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal. Neurol Sci 36(8):1515–1516
Denniston AK, Dick AD (2013) Systemic therapies for inflammatory eye disease: past, present and future. BMC Ophthalmol 24(13):18
Zhang S, Ma Y, Feng J (2015) Clinicoradiological Spectrum of Reversible Splenial Lesion Syndrome (RESLES) in Adults. Med (Baltimore) 94(6):e512
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We declare that all authors have no financial and personal relationships with other people or organizations that could have inappropriately influenced this work.
Rights and permissions
About this article
Cite this article
Wang, L., Wang, X., Shi, X. et al. Reversible lesion involving the splenium of the corpus callosum caused by phenytoin sodium withdrawal. Neurol Sci 38, 689–691 (2017). https://doi.org/10.1007/s10072-016-2773-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2773-9